We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 41

Over 40 Need Not Apply? Your Age-Neutral Recruiting Practices May Violate the ADEA
  • Hogan Lovells
  • USA
  • May 15 2018

Everyone knows that employers covered by the Age Discrimination in Employment Act (ADEA) cannot intentionally refuse to hire job applicants because


Whistleblowing While You Work: Dodd-Frank’s Antiretaliation Provision Does Not Protect Internal Reports Of Wrongdoing
  • Hogan Lovells
  • USA
  • February 22 2018

The United States Supreme Court just issued a decision in a highly anticipated whistleblower case, and unanimously held that the antiretaliation


Supreme Court limits SEC disgorgement orders to a five-year statute of limitations
  • Hogan Lovells
  • USA
  • June 6 2017

Yesterday, the Supreme Court unanimously held in Kokesh v. SEC that disgorgement orders in enforcement actions by the Securities and Exchange


Supreme Court issues major securities class action ruling
  • Hogan Lovells
  • USA
  • March 1 2013

On Wednesday, the Supreme Court held that plaintiffs in securities fraud cases do not have to establish materiality before a class can be certified


Decisions on trademark licenses in a licensor bankruptcy reinforce circuit split
  • Hogan Lovells
  • USA
  • October 25 2012

The U.S. Courts of Appeal for the Seventh and Eighth Circuits came to different conclusions in deciding the right of a trademark licensee to continue using the licensed mark after rejection or attempted rejection of the trademark license by a bankrupt licensor.


Third Circuit rules in favor of FTC view on pharmaceutical patent settlements: next stop, Supreme Court?
  • Hogan Lovells
  • USA
  • July 19 2012

On 16 July 2012, the U.S. Court of Appeals for the Third Circuit issued a decision holding that pharmaceutical patent settlements that restrict generic entry and contain a payment to the generic company are presumptively unlawful under the antitrust laws.


Supreme Court rejects whistleblower's attempt to use FOIA to forage for False Claims Act allegations
  • Hogan Lovells
  • USA
  • May 19 2011

On May 16, the Supreme Court resolved a circuit split making it clear that whistleblowers cannot file qui tam lawsuits after using the Freedom of Information Act (FOIA) to mine federal agency records for evidence to support a "hunch" or suspicion of fraud.


Dukes v. Wal-Mart Stores, Inc., Supreme Court oral argument summary
  • Hogan Lovells
  • USA
  • March 31 2011

On 29 March 2011 the Supreme Court heard oral argument in Dukes v. Wal-Mart Stores, Inc., a case that may become a landmark ruling in class action litigation.


Second Circuit's rejection of corporate liability under the alien tort statute stands
  • Hogan Lovells
  • USA
  • February 8 2011

In a short, but sharply divided decision rendered on 4 February 2011, the Second Circuit denied rehearing in banc of a 17 September 2010 panel decision in Kiobel v. Royal Dutch Petroleum holding that because corporate liability is not recognized under customary international law, federal courts do not have jurisdiction to hear cases brought against corporations under the U.S. Alien Tort Statute.


Dukes v. Wal-Mart Stores, Inc., certiorari granted
  • Hogan Lovells
  • USA
  • December 6 2010

Today the Supreme Court granted Wal-Mart's certiorari petition, agreeing to hear the company's appeal of the Ninth Circuit's significant decision in the gender discrimination class action Dukes v. Wal-Mart Stores, Inc., 603 F.3d 571 (9th Cir. 2010) during its current 2010-11 term.